AAV Rep Proteins Enhance Recombinant Protein Yield in Insect Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing recombinant proteins in insect cells using the baculovirus expression system face limitations, including lethal infection of producer cells, which hampers continuous protein production and results in suboptimal yield.
Innovation Solution
The method involves co-expressing one or more AAV Rep proteins along with a nucleic acid sequence flanked by AAV-ITRs to enhance protein expression and increase the number of transcribed copies, utilizing the AAV replication machinery to boost protein production in cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If baculovirus expression system is used to introduce gene of interest into insect cells, then recombinant protein expression level is improved, but producer cell viability deteriorates due to lethal infection
Solution Approach 1:
The patent segments the viral replication function by separating the AAV replication machinery from the baculovirus structural components. The AAV Rep proteins are expressed separately to provide replication functions, while the baculovirus provides structural framework and gene expression control, thereby reducing cytopathic effects and maintaining cell viability.
Solution Approach 2:
The patent introduces AAV Rep proteins as intermediary factors that mediate the replication of the AAV-based expression cassette. These Rep proteins act as helpers to replicate the genetic template without requiring full viral infection, thus enabling protein production while preserving cell viability.
2Productivity
If baculovirus infection is used to increase genetic templates for protein production, then protein yield is improved, but continuous production capability deteriorates due to cell death within a few days
Solution Approach 1:
The patent performs preliminary action by pre-assembling the AAV expression cassette with the gene of interest before introducing it into insect cells. This pre-assembled cassette, when replicated by AAV Rep proteins, creates multiple genetic templates that can be transcribed continuously without requiring ongoing viral infection, thereby extending production duration.
Solution Approach 2:
The patent uses AAV Rep proteins to copy the AAV expression cassette multiple times within the cell. This copying mechanism generates numerous genetic templates for protein production without the need for continuous viral replication, enabling sustained protein yield over extended periods.
3Quantity of substance
If AAV Rep proteins and AAV-ITR flanked nucleic acid sequence are co-expressed, then number of transcribed copies is increased, but system complexity increases
Solution Approach 1:
The patent merges the AAV Rep protein expression cassette with the baculovirus expression system framework. By combining these elements, the system achieves high copy number replication through AAV machinery while utilizing the well-established baculovirus infrastructure for cell culture and protein production, thereby managing complexity through integration rather than separate systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases protein expression levels, prolongs the viable life-span of infected cells, and enhances the production phase, leading to higher yields of the recombinant protein of interest.
Implementation Method 1
Co-expression of one or more AAV Rep proteins and a nucleic acid sequence flanked by AAV-ITRs increases both the expression of the protein of interest and the number of transcribed copies of the nucleic acid sequence of interest
Implementation Method 2
increases both the expression of the protein of interest and the number of transcribed copies of the nucleic acid sequence of interest
Data Source
AI summary
The present invention provides a method for enhanced production of a gene product of interest in a cell, using the AAV replication machinery. The present invention further relates to a cell for use in the method of the invention and a non-human transgenic animal or a transgenic plant comprising a cell of the invention.